56
staff
Ilana Moreno
Ilana Moreno is a Senior Associate with Feeding Change at the Milken Institute.
person
Corey Carlisle
Corey Carlisle is the Head of Public Policy for Varo Bank, the first consumer fintech to be grant
ed a national banking charter in 2020.
+ Read More
person
Sarah Timoney Paul
Sarah serves as Intuit’s Director of Global Policy and Regulatory Affairs, where she works closel
y with the business teams to ensure our policy priorities align closely with their business strategy.
+ Read More
person
Anita Gupta
report
Report and Roadmap - Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management
Chronic kidney disease (CKD) is increasingly recognized as a growing public health threat, with hig
h global prevalence and poor health outcomes. In the United States, CKD affects more than one in seven American adults, an estimated 37 million people.
+ Read More
report
Staying Power: The Effects of Short-Term Rentals on California’s Tourism Economy and Housing Affordability
Short-term rentals (STRs) are critical to regional economies, offering unique and affordable experi
ences to visitors, generating significant tax revenue to support local governments, and providing hosts significant income.
+ Read More
video
Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing
David Clifford, Robert Cook-Deegan, Steven M. Ferguson, Justin McCarthy, Lita Nelsen, Josh Sommer
video
Panel - Mental Health: Research and Development at a Crossroads
Kathi E. Hanna, Thomas R. Insel, Jay Lombard, Jeffrey Nye, Robert Ring, Paul Weiss
video
Plenary: Five People Changing the Face of Bioscience
Laura Deming, Geoffrey Ling, Jessica Richman, Josh Sommer, Halle Tecco, Adrien Treuille
video
Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns
Christopher Egerton-Warburton, Robert Hugin, Rajiv Kaul, Michael Milken, Richard Pops
video
Plenary: Big Data Needs Big Ideas
Thomas Frieden, Jeff Hammerbacher, Lesa Mitchell, Gary J. Nabel, Andy Palmer, Roni Zeiger
video
Panel: FDA: Recalibrating the Benefit-Risk Equation
Robert Conley, Geoff Duyk, Patrick Frey, Hugh Hempel, Howard McLeod, Kate Rawson